Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain D Baron

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Journal of Diabetes and Its Complications|March 2, 2002
Insulin resistance and vascular functionAlain D Baron
Current Opinion in Investigational Drugs (London, England : 2000)|June 18, 2003
Pharmacology of exenatide (synthetic exendin-4) for the treatment of type 2 diabetesLoretta L Nielsen, Alain D Baron
Current Drug Targets. Immune, Endocrine and Metabolic Disorders|December 13, 2002
Novel peptides under development for the treatment of type 1 and type 2 diabetes mellitusAlain D Baron, Dennis Kim, Christian Weyer
The New England Journal of Medicine|November 18, 2005
Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgeryThomas Carpenter, Michael E Trautmann, Alain D Baron
Diabetes Care|May 27, 2003
Weight loss and endothelial function in obesityKieren J Mather, Helmut O Steinberg, Alain D Baron
The Journal of Clinical Investigation|March 5, 2013
Insulin resistance in the vasculatureKieren J Mather, Helmut O Steinberg, Alain D Baron
Zhonghua Yi Xue Za Zhi|April 16, 2002
[Insulin mitigates the effect of free fatty acid to cause endothelial dysfunction in rat aortic rings]Yerong Yu, Jinsu Zhu, Yonggang Wu, et al.
Diabetes|March 1, 2007
Endothelin limits insulin action in obese/insulin-resistant humansAmale Lteif, Prashant Vaishnava, Alain D Baron, et al.
Diabetes|July 28, 2004
Interactions between endothelin and nitric oxide in the regulation of vascular tone in obesity and diabetesKieren J Mather, Amale Lteif, Helmut O Steinberg, et al.
Diabetes|November 28, 2002
Endothelin contributes to basal vascular tone and endothelial dysfunction in human obesity and type 2 diabetesKieren J Mather, Bahram Mirzamohammadi, Amale Lteif, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Journal of Diabetes and Its Complications|March 2, 2002
Insulin resistance and vascular functionAlain D Baron
Current Opinion in Investigational Drugs (London, England : 2000)|June 18, 2003
Pharmacology of exenatide (synthetic exendin-4) for the treatment of type 2 diabetesLoretta L Nielsen, Alain D Baron
Current Drug Targets. Immune, Endocrine and Metabolic Disorders|December 13, 2002
Novel peptides under development for the treatment of type 1 and type 2 diabetes mellitusAlain D Baron, Dennis Kim, Christian Weyer
The New England Journal of Medicine|November 18, 2005
Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgeryThomas Carpenter, Michael E Trautmann, Alain D Baron
Diabetes Care|May 27, 2003
Weight loss and endothelial function in obesityKieren J Mather, Helmut O Steinberg, Alain D Baron
The Journal of Clinical Investigation|March 5, 2013
Insulin resistance in the vasculatureKieren J Mather, Helmut O Steinberg, Alain D Baron
Zhonghua Yi Xue Za Zhi|April 16, 2002
[Insulin mitigates the effect of free fatty acid to cause endothelial dysfunction in rat aortic rings]Yerong Yu, Jinsu Zhu, Yonggang Wu, et al.
Diabetes|March 1, 2007
Endothelin limits insulin action in obese/insulin-resistant humansAmale Lteif, Prashant Vaishnava, Alain D Baron, et al.
Diabetes|July 28, 2004
Interactions between endothelin and nitric oxide in the regulation of vascular tone in obesity and diabetesKieren J Mather, Amale Lteif, Helmut O Steinberg, et al.
Diabetes|November 28, 2002
Endothelin contributes to basal vascular tone and endothelial dysfunction in human obesity and type 2 diabetesKieren J Mather, Bahram Mirzamohammadi, Amale Lteif, et al.
Pageof 3